Cormorant Asset Management, LP

Holdings History for Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Symbol: SAGE
Investment type: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2019			-0.9%	$0	0	-88,700	-100%	$14.85	Q4 2019
30 Sep 2019		0.9%	-0.11%	$12,444,000	88,700	-11,300	-11%	$140.29	Q3 2019
30 Jun 2019		1.2%	-0.35%	$18,309,000	100,000	-30,000	-23%	$183.09	Q2 2019
31 Mar 2019		1.5%	-0.61%	$20,677,000	130,000	-53,732	-29%	$159.05	Q1 2019
31 Mar 2019	put		-14%	$0	0	-184,000	-100%	$14.85	Q1 2019
31 Dec 2018		1.6%	-0.05%	$17,600,000	183,732	-6,268	-3.3%	$95.79	Q4 2018
31 Dec 2018	put	14%	+14%	$17,626,000	184,000	+184,000	NEW	$95.79	Q4 2018
30 Sep 2018		1.9%	-0.5%	$26,838,000	190,000	-49,619	-21%	$141.25	Q3 2018
30 Jun 2018		3%	0%	$37,508,000	239,619	0		$156.53	Q2 2018
31 Mar 2018		3.3%	+3.3%	$38,595,000	239,619	+239,619	NEW	$161.07	Q1 2018
30 Sep 2016			-3.1%	$0	0	-730,000	-100%	$14.85	Q3 2016
30 Jun 2016		3.1%	-0.92%	$21,995,000	730,000	-215,000	-23%	$30.13	Q2 2016
31 Mar 2016		4.6%	+3%	$30,297,000	945,000	+630,000	+200%	$32.06	Q1 2016
31 Dec 2015		2.2%	+0.52%	$18,365,000	315,000	+75,000	+31%	$58.30	Q4 2015
30 Sep 2015		1.6%	+1.6%	$10,157,000	240,000	+240,000	NEW	$42.32	Q3 2015
30 Jun 2015			-0.01%	$0	0	-850	-100%	$14.85	Q2 2015
31 Mar 2015		0.01%	-0%	$43,000	850	-150	-15%	$50.59	Q1 2015
31 Dec 2014		0.01%	-0.05%	$37,000	1,000	-9,000	-90%	$37.00	Q4 2014
30 Sep 2014		0.06%	+0.06%	$315,000	10,000	+10,000	NEW	$31.50	Q3 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.